Clinical trial

RAFT - Pace &Ablate

NCT06299514

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-04-25

PhaseNA

Study timeline

Study start (actual)2024-04-25Date precision: day

Registry last updated2026-07-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Atrial Fibrillationunresolved

Heart Failureunresolved

Pacemakerunresolved

Arrhythmia Atrialunresolved

Interventions

Pace and AblateDEVICE

MedicationDRUG

Sponsors & collaborators

Habib Khanlead sponsor

Mapped research locations

MontrealQuebec, Canada2 TorontoOntario, Canada1 OttawaOntario, Canada1 LondonOntario, Canada1 HamiltonOntario, Canada1 QuébecQuebec, Canada1 HalifaxNova Scotia, Canada1 SherbrookeQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06299514 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.